Goods & Services

Faucets; Sinks; Handheld showers; Shower head sprayers; Strainers for plumbing drains

Goods & Services

(1) Adhesive tape dispensers; art kits comprising colored pencils, paint brushes, markers, graphite pencils, pencil sharpeners, erasers, drawing pads and coloring pages; coasters of paper; cookbooks; double-sided adhesive tapes for household use; egg cartons; filter paper; flags of paper; greetings cards; microwave cooking bags; oilproof paper; paper cake decorations; paper food wrap; parchment paper; table linen of paper; table napkins of paper; table runners of paper; tablecloths of paper; waterproof paper

Abstract

A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

IPC Classes  ?

• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61L 31/04 - Macromolecular materials
• C08B 31/08 - Ethers
• C08B 31/02 - Esters
• C08B 33/04 - Ethers
• C08B 31/10 - Alkyl or cycloalkyl ethers
• C08B 31/16 - Ether-esters
• C08B 35/02 - Esters
• C08B 33/06 - Ether-esters
• C08B 35/06 - Ether-esters
• C08B 35/04 - Ethers
• C08B 33/02 - Esters
• C08B 31/12 - Ethers having alkyl or cycloalkyl radicals substituted by hetero atoms
• C08B 31/04 - Esters of organic acids
• C08B 30/20 - Amylose or amylopectin
• C08B 31/00 - Preparation of chemical derivatives of starch
• C08B 31/18 - Oxidised starch
• C08B 30/00 - Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
• A61K 31/738 - Cross-linked polysaccharides
• A61L 24/08 - Polysaccharides
• A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 9/14 - Particulate form, e.g. powders
• C08L 3/04 - Starch derivatives
• C08L 3/18 - Ethers
• C08L 89/06 - Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/19 - Particulate form, e.g. powders lyophilised
• A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
• A61L 24/10 - PolypeptidesProteins
• A61L 31/12 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material

Abstract

A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

IPC Classes  ?

• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61L 31/04 - Macromolecular materials
• C08B 31/08 - Ethers
• C08B 31/02 - Esters
• C08B 33/04 - Ethers
• C08B 31/10 - Alkyl or cycloalkyl ethers
• C08B 31/16 - Ether-esters
• C08B 35/02 - Esters
• C08B 33/06 - Ether-esters
• C08B 35/06 - Ether-esters
• C08B 35/04 - Ethers
• C08B 33/02 - Esters
• C08B 31/12 - Ethers having alkyl or cycloalkyl radicals substituted by hetero atoms
• C08B 31/04 - Esters of organic acids
• C08B 30/20 - Amylose or amylopectin
• C08B 31/00 - Preparation of chemical derivatives of starch
• C08B 30/00 - Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
• A61K 31/738 - Cross-linked polysaccharides
• A61L 24/08 - Polysaccharides
• A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 9/14 - Particulate form, e.g. powders
• C08L 3/04 - Starch derivatives
• C08L 3/18 - Ethers
• C08L 89/06 - Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/19 - Particulate form, e.g. powders lyophilised
• A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
• A61L 24/10 - PolypeptidesProteins
• A61L 31/12 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material

Abstract

A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

IPC Classes  ?

• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• C08B 31/00 - Preparation of chemical derivatives of starch
• C08B 31/08 - Ethers
• C08B 31/02 - Esters
• C08B 33/04 - Ethers
• C08B 31/10 - Alkyl or cycloalkyl ethers
• C08B 31/16 - Ether-esters
• C08B 35/02 - Esters
• C08B 33/06 - Ether-esters
• C08B 35/06 - Ether-esters
• C08B 35/04 - Ethers
• C08B 33/02 - Esters
• C08B 31/12 - Ethers having alkyl or cycloalkyl radicals substituted by hetero atoms
• C08B 31/04 - Esters of organic acids
• C08B 30/20 - Amylose or amylopectin
• C08B 30/00 - Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
• A61K 31/738 - Cross-linked polysaccharides
• A61L 24/08 - Polysaccharides
• A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

IPC Classes  ?

• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• C08B 31/02 - Esters
• C08B 31/04 - Esters of organic acids
• C08B 31/08 - Ethers
• C08B 31/10 - Alkyl or cycloalkyl ethers
• C08B 31/12 - Ethers having alkyl or cycloalkyl radicals substituted by hetero atoms
• C08B 33/02 - Esters
• C08B 33/04 - Ethers
• C08B 33/06 - Ether-esters
• C08B 35/02 - Esters
• C08B 35/04 - Ethers
• C08B 35/06 - Ether-esters
• A61K 31/738 - Cross-linked polysaccharides
• C08B 31/16 - Ether-esters
• C08B 30/00 - Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
• A61L 24/08 - Polysaccharides
• A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages

Abstract

A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

IPC Classes  ?

• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
• A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
• A61K 9/14 - Particulate form, e.g. powders
• C08L 3/18 - Ethers
• C08L 3/04 - Starch derivatives
• C08L 89/06 - Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
• C08B 31/12 - Ethers having alkyl or cycloalkyl radicals substituted by hetero atoms
• C08B 31/08 - Ethers
• C08B 31/02 - Esters
• C08B 33/04 - Ethers
• C08B 31/10 - Alkyl or cycloalkyl ethers
• C08B 31/16 - Ether-esters
• C08B 35/02 - Esters
• C08B 33/06 - Ether-esters
• C08B 35/06 - Ether-esters
• C08B 35/04 - Ethers
• C08B 33/02 - Esters
• C08B 31/04 - Esters of organic acids
• C08B 30/20 - Amylose or amylopectin
• C08B 31/00 - Preparation of chemical derivatives of starch
• C08B 30/00 - Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
• A61K 31/738 - Cross-linked polysaccharides
• A61L 24/08 - Polysaccharides
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 9/19 - Particulate form, e.g. powders lyophilised
• C08B 31/06 - Esters of inorganic acids
• A61K 9/00 - Medicinal preparations characterised by special physical form

Abstract

A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

IPC Classes  ?

• A61K 31/718 - Starch or degraded starch, e.g. amylose, amylopectin
• A61F 13/02 - Adhesive bandages or dressings
• A61F 13/53 - Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the bodySupporting or fastening means thereforTampon applicators characterised by the absorbing medium